Envoy Medical (COCH) Stock Price

Envoy Medical Price

NASDAQ·CLOSED
6.90
​
Market closed

Revenue at Envoy Medical has contracted by 6.1% per year over the past 4 years to 241,000.00 USD. For Envoy Medical, the net margin of -9,857.3% is down versus -2,798.4% a few years ago. The consensus 12-month price target for Envoy Medical is 8.42 USD, about 22.0% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Envoy Medical stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Envoy Medical business model & stock analysis

Envoy Medical Inc generates revenue through its portfolio of hearing health solutions including hearing aids, middle ear implants, bone conduction devices, and cochlear implants. The company's Esteem is a fully implanted active middle ear implant targeting adults with moderate to severe sensorineural hearing loss. Bone conduction devices feature an external component paired with a surgically implanted fixture behind the ear, offering amplification without ear molds. Hearing aids serve patients with mild to moderate hearing loss, while cochlear implants address moderate-to-profound sensorineural hearing loss. These products are sold to healthcare providers and patients seeking advanced hearing solutions within the hearing loss spectrum. The company's business model focuses on providing medical technologies that shift industry paradigms, with products designed for different severity levels of hearing loss. Hearing aids target mild to moderate cases, while cochlear implants and Esteem address more severe conditions. Bone conduction devices specifically eliminate the need for ear molds by using bone conduction technology. All solutions are positioned to serve both providers and patients requiring specialized hearing devices across the hearing loss spectrum. Envoy Medical Inc's revenue streams come from direct sales of its hearing devices to healthcare providers who then serve patients. The company's product range spans from non-invasive hearing aids for mild cases to fully implanted solutions like Esteem for severe hearing loss. Each product category targets specific patient segments based on hearing loss severity, ensuring tailored solutions for different needs within the hearing health market.

Frequently asked questions about Envoy Medical

Analysts currently set an average price target of 8.42 USD for the Envoy Medical stock (median: 8.42 USD), implying +21.6 % versus the latest price. The consensus is based on 7 analyst ratings.

9 analysts currently rate the Envoy Medical stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Envoy Medical to generate revenue of 133,333.00 USD and earnings per share of -1.64 USD.

Converted at the current exchange rate, the Envoy Medical share trades at 6.27 EUR (6.90 USD).

The Envoy Medical share (COCH) is listed on 1 stock exchanges, including: NASDAQ (COCH).

The expected revenue of Envoy Medical is 133,333.00 USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Envoy Medical is -75.53 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Envoy Medical is currently -4.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Envoy Medical stock.

The price-to-sales ratio (P/S) of Envoy Medical is currently 2,385.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Envoy Medical stock.

The Eulerpool Quality Score for Envoy Medical is 5/10.

The ISIN of Envoy Medical is US29415V1098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Envoy Medical is COCH. The ticker symbol is used to trade Envoy Medical shares on the stock exchange.

Fair ValueTerminal
5.66 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website anzuspac.com
Currency
USD
Initial public offering
Mar 2, 2021
ISIN
US29415V1098
Cusip
29415V109
Market capitalization
198.65 M USDMicro Cap
52-Week Range
PEG
4.11
P/E ratio
P/Ee 2026
-4.21
P/Ee 2027
-4.53
P/Ee 2028
-4.65
P/Ee 2029
—
P/Se
2,385.51
EV/EBIT
—
P/B Ratio
8,175.16
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
218.99 %
Last updated Nov 18, 2026, 9:56 AM

Envoy Medical Peer Group

Envoy Medical Ticker

NASDAQ · COCH

Envoy Medical FIGI

COCH:US · BBG00Z6RQKY6COCH:UA · BBG00Z913TT2COCH:UC · BBG00Z913TV9COCH:UN · BBG00Z913TX7COCH:UP · BBG00Z913TY6COCH:UB · BBG00Z913V08COCH:UM · BBG00Z913V26COCH:UX · BBG00Z913V35COCH:UR · BBG00Z913V44COCH:UD · BBG00Z913V80COCH:UF · BBG00Z913VC5COCH:VY · BBG00Z913VD4